Skip to main content
FinSpry Logo
FinSpry
GANX logo
GANX
(NASDAQ)
Gain Therapeutics, Inc.
$1.85-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Gain Therapeutics (GANX) Stock Price & Financial Analysis

Gain Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.83 - $1.96
52-Week High$4.34
52-Week Low$1.41
Open$1.89
Volume518.97K
Average Volume (3M)518.97K
Market Cap64.75M
Shares Outstanding35.00M
Price to Book (P/B)11.49
EV/EBITDA-3.40
50-Day MA$2.13
200-Day MA$2.16
52-Week Change7.18%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Gain Therapeutics

What is the current stock price for GANX?

As of the latest trading session, GANX stock trades at $1.85. The 52-week range is $1.41–$4.34, with a day range of $1.83–$1.96.

What is the P/E ratio for GANX?

The P/E ratio (Price-to-Earnings) for GANX is shown in the Key Statistics section. This valuation metric helps compare Gain Therapeutics, Inc. to industry peers.

Does GANX pay dividends?

Gain Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GANX?

Analyst ratings and recommendations for GANX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of GANX?

Gain Therapeutics's market capitalization is $64.7M, classifying it as a micro-cap company. Gain Therapeutics operates in the Healthcare sector within the Biotechnology industry.